Carolinas Wealth Consulting LLC Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Carolinas Wealth Consulting LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,076 shares of the healthcare conglomerate’s stock after selling 68 shares during the period. Carolinas Wealth Consulting LLC’s holdings in UnitedHealth Group were worth $1,050,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Mizuho cut their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Raymond James cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research note on Wednesday, May 14th. Oppenheimer cut their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Finally, TD Securities reaffirmed a “hold” rating and issued a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Stock Down 0.4%

Shares of NYSE UNH opened at $295.37 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $267.94 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm has a fifty day simple moving average of $452.40 and a two-hundred day simple moving average of $503.72.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the company posted $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares of the company’s stock, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.